To view this email as a web page, click here

Today's Rundown

Featured Story

Novartis and Roche tee up self-injected Xolair option with FDA filing for prefilled syringe

Novartis and Genentech want to put their injectable asthma drug Xolair directly into patients' hands—and they've filed their prefilled syringe version for FDA approval to do just that. If the agency grants a green light, Xolair could be administered at home, a convenience made even more important by the COVID-19 pandemic.

read more

Top Stories

Robotic jaws could make medicated chewing gum trials easier to swallow

Researchers have come up with a high-tech way to test medicated gum: A set of robotic jaws that closely mimic human chewing patterns and even release artificial saliva. In a study that compared the chewing bot with human subjects, the jaws triggered drug release from xylitol-infused gum on par with human subjects.

read more

Roche takes on Alexion, Viela Bio with newly approved NMOSD drug Enspryng

Treatment for neuromyelitis optica spectrum disorder has transformed over the last year with FDA approvals for Alexion‘s Soliris and Viela Bio’s Uplizna, but now pharma giant Roche is entering the fray. Enspryng, formerly known as satralizumab, has scored an FDA approval.

read more

Xeris' glucagon injection Gvoke gains heat with HypoPen auto-injector launch

In July, diabetes drugmaker Xeris Pharmaceuticals launched its Gvoke HypoPen, a glucagon auto-injector approved to treat severe hypoglycemia. With some quick pandemic footwork and strong early adoption, HypoPen has soared during its first month at market; now, at least one group of analysts are hailing it as an "Epipen" for diabetes patients.

read more

Medtronic snaps up smart insulin pen maker Companion Medical in a 'bold move'

Medtronic is buying up leading smart insulin pen and connected phone app maker Companion Medical as it looks to shore up its growing weakness in the pump market.

read more

Enrollment Showcase

Bioscience Certificate Pathways Advancing Knowledge, Skills, & Careers

Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more.

Resources

Report: Decentralized Trials - Where Does the Industry Stand?

Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual."

Whitepaper: Navigating the Changing Clinical Trial Landscape

The research conducted here is to help understand and solve the top challenges in clinical operations, to remove barriers that are slowing down our ability to bring new drugs to market as quickly as possible to patients waiting in need.

Whitepaper: Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs

How to select the right dosage form for your Phase I clinical supply.

Whitepaper: Quality by Design: A Holistic Approach to Drug Development

Quality by Design (QbD) reduces risk within drug development, while bringing therapies to market quicker.

Webcast: DRUG ABUSE LIABILITY ASSESSMENT: Are you taking an integrated approach?

Two informative webcasts will present practical and methodological approaches to preclinical drug abuse liability assessment

Executive Summary: Keys to a Successful Rapid Commercial Launch

Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better.

Whitepaper: Reducing the Complexity and Costs of Channel Planning and Logistics

Identifying opportunities to simplify channel strategies and business processes for biopharma companies, their customers and patients.

Whitepaper: More Powerful Analytics Capabilities

Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI.

eBook: Navigating the Insulin Affordability Act

Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all.

Whitepaper: The Art of Recognizing Clinical Supply Risk Factors

In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management.

Paid Marketplace: Want to Change the World? Join the Phlow Corp. Team

Interested in putting patients, people, and planet over profit in a fast-paced environment? Please Apply: VP of Integrated Supply Chain and VP of Manufacturing, Science, & Technology

Whitepaper: Learn How to Navigate Pediatric Clinical Trials Under the New RACE Act

Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need.

Video: How to Put Real World Data into Action

Accurate, timely insights are everything. Whatever the question, the answers demand real world data you can trust. Healthy data advances reliable insights, and takes the error out of AI. Healthy data is not just useable, but invaluable. Healthy data starts with InterSystems.